Who
In numbers
- Trades disclosed
- 30
- Buys
- 7
- Sells
- 1
- Bought
- $910K
- Sold
- $9,045
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 16 Jun 2015
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | LPCN LipocineBiotechnology | SEC FORM 4 Bought | $36K15,970 at $2.23 | filing |
| 29 Sep 2026filed 1 Oct 2026 | LPCN LipocineBiotechnology | SEC FORM 4 Bought | $19K9,037 at $2.15 | filing |
| 28 Sep 2026filed 30 Sep 2026 | LPCN LipocineBiotechnology | SEC FORM 4 Bought | $27K12,561 at $2.16 | filing |
| 28 Sep 2026filed 30 Sep 2026 | LPCN LipocineBiotechnology | SEC FORM 4 Bought | $27K12,561 at $2.16 | filing |
| 3 Jun 2026filed 4 Jun 2026 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $3,8631,764 at $2.19 | filing |
| 3 Jun 2026filed 4 Jun 2026 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $3,8631,764 at $2.19 | filing |
| 7 Apr 2026filed 7 Apr 2026 | LPCN LipocineBiotechnology | SEC FORM 4 Bought | $81K40,000 at $2.03 | filing |
| 7 Apr 2026filed 7 Apr 2026 | LPCN LipocineBiotechnology | SEC FORM 4 Bought | $81K40,000 at $2.03 | filing |
| 6 Apr 2026filed 6 Apr 2026 | LPCN LipocineBiotechnology | SEC FORM 4 Bought | $252K123,000 at $2.05 | filing |
| 6 Apr 2026filed 6 Apr 2026 | LPCN LipocineBiotechnology | SEC FORM 4 Bought | $252K123,000 at $2.05 | filing |
| 4 Jun 2025filed 5 Jun 2025 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $5,6451,764 at $3.20 | filing |
| 5 Jun 2024filed 7 Jun 2024 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $12K1,764 at $7.05 | filing |
| 10 May 2023filed 12 May 2023 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $8,10030,000 at $0.27 | filing |
| 8 Jun 2022filed 10 Jun 2022 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $20K22,000 at $0.92 | filing |
| 9 Jun 2021filed 10 Jun 2021 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $28K22,000 at $1.26 | filing |
| 31 Dec 2020filed 4 Jan 2021 | LPCN LipocineBiotechnology | SEC FORM 4 Sold | $2,2951,700 at $1.35 | filing |
| 31 Dec 2020filed 4 Jan 2021 | LPCN LipocineBiotechnology | SEC FORM 4 Sold | $6,7505,000 at $1.35 | filing |
| 16 Dec 2020filed 17 Dec 2020 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 16 Dec 2020filed 17 Dec 2020 | LPCN LipocineBiotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 10 Jun 2020filed 10 Jun 2020 | LPCN Lipocineoption or derivative · Biotechnology | SEC FORM 4 Code A | $21K22,000 at $0.96 | filing |
News
Lipocine (NASDAQ:LPCN) & Harmony Biosciences (NASDAQ:HRMY) Head-To-Head AnalysisLPCN · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name John W. Higuchi; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.